Nuvectis Pharma, Inc. - Common Stock — Cash Flow (NASDAQ:NVCT) | MetaTrader

Open full chart

Financials

Overview Statement Statistics Documents

Cash from operating activities -13.56 M-15.95 M-12.25 M-16.01 M -19.51 M Cash from investing activities —000 — Cash from financing activities 27.81 M15.09 M11.65 M29.11 M 14.88 M Free cash flow -13.56 M-15.95 M-12.25 M-16.01 M -19.51 M

News

HC Wainwright & Co. Reiterates Buy on Nuvectis Pharma, Maintains $39 Price Target

Nuvectis Pharma's NXP200 BRAF Inhibitor Receives China's Breakthrough Therapy Designation

Nuvectis Pharma:Haisco Licensing Deal Revitalises Biotech, But No Rush To Invest Now(NVCT)

This Brinker International Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Mond

Nuvectis Stock Surges Around 97% in 3 Months: Here's Why

Wall Street Analysts Predict a 56.41% Upside in Nuvectis Pharma (NVCT): Here's What You Should Know

Wall Street Analysts See a 61.46% Upside in Nuvectis Pharma (NVCT): Can the Stock Really Move This High?

PepsiCo, Delta Air Lines To Report Earnings; FOMC's Minutes Of The Meeting In Focus

Nuvectis: 'Hold' On NXP800 Removal And Newly Licensed Candidates (NASDAQ:NVCT)

What Makes Nuvectis Pharma, Inc. (NVCT) a Strong Momentum Stock: Buy Now?

Biotech Is The Rate Cut Trade In Disguise

What Makes Nuvectis Pharma (NVCT) a New Buy Stock